RESOURCES

Use Cases

How Pharma & Agencies put the signals to work

Blogs

Intelligence at the intersection of data science and real-life health

The Talking Room

Demystifying AI, LLMs and machine learning

Compliance Hub

Data integrity, ethical AI and regulatory standards

DrugVoice

Built to be defensible.

Compliance, ethics, and data integrity are part of the process.

TMLABS

About TMLabs

Where our proprietary models are trained, tested and refined

Articles & scientific publications

Methodologies and validated outcomes

Latest paper

Understanding Unstructured Consumer Conversations in the GLP-1 Space

Articles & Scientific Publications

DRUGVOICE

DrugVoice

Measure how your messaging lands and evidence change

SEE IT IN ACTION

Challenge us!

See which messages resonate with different audiences, understand why, and where relevant, examine their association with intent-to-prescribe.

ABOUT US

About us

Our story, our mission and the people behind it

ESG

Responsible innovation and ethical data practice

WHO WE ARE

Challenge us!

A team built around one problem: making real-life conversation usable at scale.

Article

From Agentic AI to Federated Learning: Key AI Innovations from GTC 2025

Mar 27, 2025

← All articles

In this article

Share

The NVIDIA GTC 2025 conference offered a front-row seat to the most transformative innovations in AI, and healthcare was front and center. From federated learning to Agentic AI, and from high-speed sequencing to real-time data visualization, the sessions painted a compelling picture of how intelligent technologies are reshaping our approach to healthcare analytics.

Here’s a round-up of the most impactful trends shaping the future of healthcare through AI:

Human-in-the-Loop: Domain Expertise Meets Intelligent Automation

One of the strongest signals throughout the conference was the continued importance of human-in-the-loop (HITL) approaches, especially in complex sectors like healthcare. As powerful as Large Language Models (LLMs) and AI agents are becoming, their accuracy and impact depend heavily on clinical context and subject-matter expertise.

Integrating domain experts into the data annotation and validation process not only improves model quality but ensures AI-generated insights are relevant, safe, and interpretable—especially for improving better health outcomes.

Data Integration: From Fragmentation to Intelligence

Healthcare data remains one of the most fragmented assets in the industry. From EHRs to patient-reported outcomes, the challenge isn’t data scarcity—it’s connectivity and curation.

The discussions at GTC 2025 highlighted the growing emphasis on smart, unified data ecosystems that can bridge clinical research and real-world evidence. The path forward is clear: curated and interoperable datasets that support real-time analytics, predictive care models, and AI-powered decision support systems.

Agentic AI: Planning, Reasoning, and Acting with Purpose

The rise of Agentic AI—models that don’t just respond to prompts, but plan, reason, and act—is opening new frontiers for healthcare applications. Unlike traditional automation, agentic AI systems are designed to handle complex, multi-step tasks, enabling new use cases in diagnostics, treatment simulations, and health system management.

These systems offer the promise of adaptive intelligence—AI that works in partnership with human teams to solve evolving, real-world challenges in Patient care and medical research.

Visualization at GPU Speed

Traditional CPU-based tools simply can’t keep up with the scale and speed required to process and render the dynamic data streams common in healthcare.

Whether tracking shifts in patient sentiment or visualising treatment pathways across populations, the ability to explore data in real-time is fast becoming essential—and GPUs are leading that charge.

Synthetic Data, LLM Judges & Federated Learning

Ethical, scalable AI in healthcare depends on solving the data access paradox: how to use sensitive patient data without compromising privacy.

Three technologies are converging to solve this:

  • Synthetic data enables robust model training without exposing real patient records.

  • LLM judges—AI models that assess and refine outputs from other models—are helping create intelligent feedback loops that enhance scalability and accuracy.

  • Federated learning keeps data where it lives, allowing institutions to collaborate on model training without moving or exposing private information.

Together, these advancements are making it possible to build trustworthy AI systems that scale safely across healthcare ecosystems.

High-Speed Sequencing & Predictive Care

With the accelerating pace of sequencing technology, predictive and personalized healthcare is no longer a future concept—it’s happening now. What stood out at GTC was how AI is being paired with high-throughput genomics and diagnostics to develop treatment plans tailored not just to conditions, but to individuals.

When layered with patient-reported outcomes and behavioural data, these tools are unlocking a truly patient-centric model of care.

Final Thoughts: What It Means for Talking Medicines

At Talking Medicines, our mission is to be the world’s gold standard provider of structured intelligence on health-related data —backed by smart data, curated insights, and AI models built for healthcare.

What we saw at GTC 2025 reinforced that:

  • AI must be interpretable, inclusive, and domain-aware.

  • Curated, integrated data is more valuable than sheer volume.

  • And the combination of human expertise with scalable, agentic systems is what will truly unlock value in healthcare.

GTC confirmed what we already believe: AI is not just a tool—it’s a collaborator in designing a better future for healthcare.

Stay ahead of message impact

Know which messages change behaviour, before the prescriptions are written.

Transforming millions of real-life conversations into curated intelligence.

Evidence-led insights powered by DrugVoice and the Message Resonance™ Score. Roughly two a fortnight, straight from the teams building the models.

Subscribe on LinkedInFollow Talking Medicines

Keep reading

More from the same topic.

Loading...